Home > Insider Trading > Filing (0001209191-20-046182)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1724521	Arcus Biosciences Inc.	RCUS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1182473	J Terry Rosen	C/O Arcus Biosciences, Inc. 3928 Point Eden Way Hayward CA 94545	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-08-07	11,655	$21.44	3,199,129	No	4	P	Indirect	By The Rosen Family Trust
Common Stock	Acquisiton	2020-08-10	32,050	$23.38	3,231,179	No	4	P	Indirect	By The Rosen Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By The Rosen Family Trust
No	4	P	Indirect	By The Rosen Family Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	189,393	Direct
Common Stock	398,350	Indirect	By Rosen GRAT No. 1
Common Stock	437,315	Indirect	By Rosen GRAT No. 2

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.11 to $21.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
101,650 and 62,685 shares previously held by the reporting person in Rosen GRAT No. 1 and No. 2, respectively, were transferred into the Rosen Family Trust in a transaction exempt from Section 16 reporting pursuant to Rule 16a13.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.69 to $23.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.